Manulife (Manufacturers Life Insurance)
RVMD icon

Manulife (Manufacturers Life Insurance)’s Revolution Medicines RVMD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
58,991
-82,305
-58% -$12M 0.01% 848
2026
Q1 		$13.7M Sell
141,296
-30,247
-18% -$3.05M 0.01% 716
2025
Q4 		$13.7M Buy
171,543
+2,133
+1% +$140K 0.01% 750
2025
Q3 		$7.91M Buy
169,410
+3,024
+2% +$118K 0.01% 985
2025
Q2 		$6.12M Sell
166,386
-73,709
-31% -$2.83M 0.01% 1075
2025
Q1 		$8.49M Buy
240,095
+2,556
+1% +$104K 0.01% 917
2024
Q4 		$10.4M Buy
237,539
+24,698
+12% +$1.25M 0.01% 867
2024
Q3 		$9.65M Buy
212,841
+473
+0.2% +$20.6K 0.01% 905
2024
Q2 		$8.24M Buy
212,368
+13,318
+7% +$498K 0.01% 913
2024
Q1 		$6.42M Buy
199,050
+20,063
+11% +$595K 0.01% 1082
2023
Q4 		$5.13M Buy
178,987
+23,451
+15% +$564K ﹤0.01% 1161
2023
Q3 		$4.31M Buy
155,536
+18,204
+13% +$540K ﹤0.01% 1186
2023
Q2 		$3.67M Buy
137,332
+1,958
+1% +$48K ﹤0.01% 1221
2023
Q1 		$2.93M Buy
135,374
+41,980
+45% +$1.03M ﹤0.01% 1282
2022
Q4 		$2.24M Buy
93,394
+4,796
+5% +$102K ﹤0.01% 1354
2022
Q3 		$1.74M Buy
88,598
+4,729
+6% +$104K ﹤0.01% 1420
2022
Q2 		$1.61M Buy
83,869
+597
+0.7% +$11.6K ﹤0.01% 1475
2022
Q1 		$2.13M Buy
83,272
+52,428
+170% +$1.14M ﹤0.01% 1485
2021
Q4 		$784 Buy
30,844
+404
+1% +$11.4K ﹤0.01% 1988
2021
Q3 		$837K Sell
30,440
-2,488
-8% -$72.4K ﹤0.01% 1958
2021
Q2 		$1.04M Buy
32,928
+9,496
+41% +$331K ﹤0.01% 1971
2021
Q1 		$1.07M Buy
23,432
+974
+4% +$43.7K ﹤0.01% 1831
2020
Q4 		$889K Buy
22,458
+1,710
+8% +$67.6K ﹤0.01% 1886
2020
Q3 		$722K Buy
20,748
+12,246
+144% +$339K ﹤0.01% 1811
2020
Q2 		$260K Buy
+8,502
New +$267K ﹤0.01% 2348

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RVMD Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Revolution Medicines (RVMD) stake by 58% in Q2 2026, selling an estimated $12M and leaving 58,991 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #848.

Manulife (Manufacturers Life Insurance) first reported a position in RVMD in Q2 2020 and has held it in 25 quarters since. The position peaked at $13.7M in Q1 2026. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 58,991 shares of Revolution Medicines worth $11M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 82,305 Revolution Medicines shares in Q2 2026, an estimated $12M.
  • Revolution Medicines made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #848 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Revolution Medicines in Q2 2020 and has held it in 25 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Revolution Medicines position peaked at $13.7M in Q1 2026.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.